These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8014003)

  • 21. Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants.
    Beguin Y; Oris R; Fillet G
    Bone Marrow Transplant; 1993 Apr; 11(4):285-92. PubMed ID: 8485476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Erythropoietin treatment of anemia associated with multiple myeloma (MM) and myelodysplastic syndrome (MDS)].
    Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):122-4. PubMed ID: 8223121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human erythropoietin (rhEPO) administration to marrow donors. Bone Marrow Transplantation (BMT) Team.
    Akiyama H; Tanikawa S; Takamoto S; Sakamaki H; Sasaki T; Onozawa Y
    Int J Hematol; 1995 Oct; 62(3):145-9. PubMed ID: 8589358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
    Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
    Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human erythropoietin for long-term persistent anemia after major ABO-incompatible bone marrow transplantation.
    Taniguchi S; Yamasaki K; Shibuya T; Asayama R; Harada M; Niho Y
    Bone Marrow Transplant; 1993 Oct; 12(4):423. PubMed ID: 8275046
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythropoietin therapy in cancer patients.
    Doweiko JP; Goldberg MA
    Oncology (Williston Park); 1991 Aug; 5(8):31-7; discussion 38, 43-4. PubMed ID: 1834151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of erythropoietin in oncology].
    Rosso R; Del Mastro L; Venturini M; Bergaglio M; Pasquetti W; Garrone O
    Tumori; 1997; 83(4 Suppl 2):S26-30. PubMed ID: 9487381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin: current status.
    Bunn HF
    Yale J Biol Med; 1990; 63(5):381-6. PubMed ID: 2293499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal anemia: from incurable to curable.
    Sato Y; Yanagita M
    Am J Physiol Renal Physiol; 2013 Nov; 305(9):F1239-48. PubMed ID: 23884144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human erythropoietin may correct erythropoietin-deficient hyporegenerative anaemia in children given cardiac transplantation.
    Locatelli F; Zecca M; Mamprin F; Gamba A; Giorgiani G; De Stefano P
    Br J Haematol; 1994 Nov; 88(3):623-5. PubMed ID: 7819078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The production of recombinant human erythropoietin.
    Inoue N; Takeuchi M; Ohashi H; Suzuki T
    Biotechnol Annu Rev; 1995; 1():297-313. PubMed ID: 9704092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation.
    Locatelli F; Zecca M; Ponchio L; Beguin Y; Giorgiani G; Maccario R; Bonetti F; De Stefano P; Cazzola M
    Bone Marrow Transplant; 1994 Dec; 14(6):929-35. PubMed ID: 7536073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation.
    Locatelli F; Zecca M; Beguin Y; Giorgiani G; Ponchio L; De Stefano P; Cazzola M
    Br J Haematol; 1993 Aug; 84(4):752-4. PubMed ID: 8217839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemical structure, biotechnical production and clinical use of recombinant erythropoietin].
    Fandrey JK; Jelkmann WE
    Z Gesamte Inn Med; 1992 Jun; 47(6):231-8. PubMed ID: 1642021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
    Rainville N; Jachimowicz E; Wojchowski DM
    Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human erythropoietin and the anemia of multiple myeloma.
    Barlogie B; Beck T
    Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human erythropoietin for treatment of myelodysplastic syndromes.
    Rafanelli D; Grossi A; Longo G; Vannucchi AM; Bacci P; Ferrini PR
    Leukemia; 1992 Apr; 6(4):323-7. PubMed ID: 1588794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation.
    Abedi MR; Bäckman L; Boström L; Lindbäck B; Ringdén O
    Bone Marrow Transplant; 1990 Aug; 6(2):121-6. PubMed ID: 2207449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis].
    García Martín F; Carrascosa Vallejo T; Martín Escobar E; Val Begueria J; Martín Hernández R; de Arriba G; Teno C; Salvatierra J
    Rev Clin Esp; 1990 May; 186(9):419-22. PubMed ID: 2247677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.